Dr Maria Kinali is a Consultant Paediatric Neurologist with special interests in childhood neuromuscular diseases, neurogenetics and neurorehabilitation. In 1999 she coordinated the UK steroid trial in DMD involving the smooth integration of a study in 14 UK neuromuscular Centres. She contributed to her interest in translational research by setting up a Rare Diseases biological samples bank (Biobank) for research to facilitate pharmacological, gene and cell therapy trials in NMD. Between April 2005-May 2009 I worked as a Senior Clinical Research Fellow, at both Imperial College and subsequently the Institute of Child Health, London, coordinating a Phase I/II Clinical Trial using a Morpholino Antisense Oligonucleotide (AVI-4658) in Duchenne Muscular Dystrophy.
Dr Kinali achieved her primary medical qualification (Ptychio Iatrikes) in 1992 at the University of Patras, completing an MD in the management and long-term outcomes in Duchenne Muscular Dystrophy and contributing in the delineation of the natural history of several neuromuscular disorders (NMD).